Who is sponsoring NCT05410561?

NCT05410561 is sponsored by University of Michigan.

What drugs are being tested in NCT05410561?

Interventions in NCT05410561: Enhanced Usual Care (EUC), TeleTx intervention.

What condition does NCT05410561 study?

NCT05410561 studies Substance Use Disorders, Substance Use, Substance Dependence.

Is NCT05410561 still recruiting?

NCT05410561 is currently active, enrolled. Last updated 22 September 2025.

Last reviewed 2025-09-22 · How we verify

NCT05410561

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients

Active, enrolled NA Last updated 22 September 2025

What this trial tests

NA trial testing Enhanced Usual Care (EUC) in Substance Use Disorders in 300 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 November 2022

Primary endpoint
30 April 2026

30 April 2026

Quick facts

Lead sponsor	University of Michigan
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	300
Start date	1 November 2022
Primary completion	30 April 2026
Estimated completion	30 April 2026
Sites	2 locations across United States

Drugs / interventions tested

Enhanced Usual Care (EUC)
TeleTx intervention

Conditions studied

Substance Use Disorders — all drugs for Substance Use Disorders →
Substance Use — all drugs for Substance Use →
Substance Dependence — all drugs for Substance Dependence →

Sponsor

University of Michigan

Who can join

Adults 18 to 75, any sex, with Substance Use Disorders or Substance Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this trial is to test new programs to see if they might help people manage their health and health behaviors related to alcohol use and well-being. The program sessions focus on getting to know what's important to the participants, reviewing or setting goals, and using different skills and behaviors to better manage health. The trial will help the study team learn about ways to deliver health information in a way that is useful and interesting. This research will take place remotely (e.g., Zoom, Facetime, Phone) and participants will be randomized to the Telehealth (TeleTx) group intervention or the Enhanced Usual Care (EUC) control group. Both groups will be asked to have follow-up visits up to 12 months from the baseline visit.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Testing a new model of telehealth-delivered treatment for primary care patients with alcohol use disorder: A randomized controlled trial protocol.
Bonar EE, Goldstick JE, Rostker MJ, Dailey SE, et al · · 2024 · cited 3× · PMID 38679140 · DOI 10.1016/j.cct.2024.107549
Unhealthy alcohol use detection in electronic health records: A comparative study using natural language processing.
Ju X, Solka J, Weber K, Vydiswaran VV, et al · · 2025 · PMID 41109081 · DOI 10.1016/j.drugalcdep.2025.112920

Verify or expand the search:

Other trials of Enhanced Usual Care (EUC)

Trials testing the same drug.

NCT06811454 — Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) · NA · not yet recruiting
NCT06208293 — Suicide Prevention Integration Into Task-shifted Mental Health Interventions · NA · completed
NCT06277661 — The Mom and Infant Outcomes (MOMI) Study · NA · recruiting
NCT05576467 — Treatment for Migraine and Mood · NA · active not recruiting
NCT06248203 — Teachers Leading the Front Lines - Adolescent · NA · recruiting

Other recruiting trials for Substance Use Disorders

Currently open trials in the same condition.

NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
NCT07529327 — Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups an · NA · recruiting
NCT07281261 — tAN for Substance Use Disorder · NA · recruiting
NCT07210268 — Temporal Interference Methods for Addiction Treatment · NA · recruiting
NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting

Other University of Michigan trials

Trials by the same sponsor.

NCT07536919 — Integrating Care for Hypertension-Diabetes MULTImorbidity in Guatemala Through HEARTS Implementation · NA · not yet recruiting
NCT05509842 — Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) · NA · not yet recruiting
NCT06311188 — Exploring PTSD Symptoms, Barriers and Facilitators to Mindfulness · NA · not yet recruiting
NCT07471646 — Effects of Ramadan Fasting With Exercise on Cardiometabolic Health · NA · not yet recruiting
NCT06671925 — A Community Health Worker-Led Program for Chronic Pain and Loneliness in Older Adults · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05410561 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Michigan
Last refreshed: 22 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05410561.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing